Stoke、Iovance和Context Therapeutics根据纳斯达克的诱因规则向新员工授予股票期权，以吸引生物技术人才。 Stoke, Iovance, and Context Therapeutics granted stock options to new hires under Nasdaq’s inducement rule to attract biotech talent.

Stoke Therapeutics、Iovance Biotherapeutics和Context Therapeutics均宣布根据纳斯达克的诱导奖励规则向新员工授予股票期权，该规则允许公司在招聘关键人员时无需股东批准即可授予股权。 Stoke Therapeutics, Iovance Biotherapeutics, and Context Therapeutics each announced stock option grants to new employees under Nasdaq’s inducement award rule, which allows companies to grant equity without shareholder approval when hiring key personnel. 这些举动是生物技术部门吸引人才的更广泛努力的一部分。 The moves are part of broader efforts to attract talent in the biotechnology sector. 公告中没有提供关于股票数量或罢工价格的具体细节。 Specific details on the number of shares or strike prices were not provided in the announcements.